Glabridin inhibits osteosarcoma cell migration and invasion by suppressing p38 and JNK pathway activation, preventing CREB-AP1 complex formation, and reducing MMP-2 and MMP-9 expression. The gene discussed is CREB1; the disease is osteosarcoma.